Nutanix grew FY2026 revenue 12% to $2.85 billion and expanded non-GAAP operating margin to 23.7%, but its eightfold jump in GAAP net income to $1.51 billion came almost entirely from a $1.2 billion non-cash release of its U.S. deferred-tax valuation allowance.
The headline number is real. The one that moved most is not.
Nutanix closed its fiscal 2026 on July 31, 2026 (the company's fiscal year ends in July, so "FY2026" covers August 2025 through July 2026) with revenue of $2,853.5 million, up 12% from $2,537.9 million, and reported GAAP net income of $1,506.8 million against $188.4 million the year before — an eightfold jump.
Almost none of that jump came from the business. Income before taxes rose from $211.6 million to $327.1 million, a respectable 55%. The rest is a single accounting entry: Nutanix recorded a $1,179.7 million net tax benefit instead of last year's $23.3 million tax expense, driven by the release of $1,208.2 million of its valuation allowance on U.S. deferred tax assets (10-K, MD&A: "The year-over-year decrease in the provision for income taxes in fiscal 2026 was due primarily to the release of $1,208.2 million of our valuation allowance on the majority of our U.S. federal and state deferred tax assets"). Cash taxes actually paid in FY2026 were $30.3 million — lower than FY2025's $32.5 million. The billion-dollar gain never touched the bank account.
What it does mark is a milestone. A valuation allowance is a bookkeeping haircut a company takes against tax losses it doesn't yet believe it will ever be profitable enough to use. Releasing it means the auditors and management now think those losses will get used. The 10-K states the test plainly: "As of July 31, 2026, we reported a cumulative three-year U.S. pre-tax profit and sustained profitability in recent operating periods. This information is both objective and verifiable; thereby representing strong positive evidence that carries significant weight." After years of losses, Nutanix has cleared the three-year cumulative-profit bar in the U.S.
The mechanical consequences are visible across the balance sheet. The deferred tax asset went from $17.0 million to $1,215.8 million, the valuation allowance fell from $1.3 billion to $124.4 million, and total stockholders' equity flipped from a $694.5 million deficit to $702.6 million positive — the accumulated deficit shrank from $4,895.7 million to $3,708.6 million. Nutanix still holds roughly $1.7 billion of federal and $1.3 billion of state net operating loss carryforwards plus $246.3 million of federal R&D credits, which will shelter most of its U.S. cash taxes for years even as GAAP tax expense now shows up normally.
Read 0 community reports on Nutanix, Inc., or write your own.Write a report
Metric
FY2026 (yr ended 7/31/26)
FY2025 (yr ended 7/31/25)
YoY Change
Total revenue
$2,853.5M
$2,537.9M
+12%
Annual recurring revenue (ARR)
$2,548.8M
$2,201.7M
+16%
GAAP gross margin
86.8%
86.8%
flat
GAAP operating income (margin)
$274.0M (9.6%)
$172.5M (6.8%)
+$101.5M (+280 bps)
Non-GAAP operating margin
23.7%
21.1%
+260 bps
GAAP net income
$1,506.8M
$188.4M
+$1,318.5M
GAAP diluted EPS
$5.17
$0.65
+$4.52
Non-GAAP diluted EPS
$2.04
$1.62
+26%
Free cash flow
$840.7M
$750.2M
+12%
Remaining performance obligations
$3,440.4M
$2,692.6M
+28%
ARR (annual recurring revenue) is the annualized value of all subscription contracts in force at period end, a way of measuring the subscription base without the distortion of contracts signed for different lengths. Note that Nutanix changed its ARR calculation in Q1 FY2026 to align with when licenses are made available to customers, and restated prior periods to match, so the 16% is comparable. Free cash flow is operating cash flow minus capital spending — $916.7M less $76.0M of property and equipment purchases.
The unusual direction of the GAAP/non-GAAP gap
Almost every software company reports non-GAAP earnings above GAAP earnings, because the main adjustment is adding back stock-based compensation. Nutanix did that too — it excluded $357.7 million of stock compensation (12.5% of revenue) plus $27.6 million of restructuring and $14.9 million of legal fees, which is what turns a 9.6% GAAP operating margin into a 23.7% non-GAAP one.
But at the net income line the sign reverses: GAAP diluted EPS of $5.17 is more than double the $2.04 non-GAAP figure, because the reconciliation subtracts the entire $1,208.2 million valuation allowance release and applies a flat 20% assumed long-term tax rate instead of the actual benefit. Non-GAAP net income was $596.8 million versus $475.7 million a year earlier, +25%.
For anyone modeling FY2027, the practical point is that GAAP EPS is about to fall by roughly $3 per share for reasons that have nothing to do with operations. The valuation allowance can only be released once; from here Nutanix carries a normal-looking tax provision on its income statement, even though the NOL carryforwards mean the cash tax bill stays low.
Growth is decelerating; the recurring base is not
The three-year revenue trend in the 10-K's own key-metrics table is the number worth sitting with: +15% in FY2024, +18% in FY2025, +12% in FY2026. FY2026 was the slowest of the three despite what is supposed to be the company's best competitive setup in a decade.
The composition:
Product revenue (mostly upfront-recognized software licenses) grew 11% to $1,489.7 million, attributed in MD&A to "increases in software revenue as a result of increased adoption of our products, driven by growth in software renewals and the various programs we have put in place to attract new customers."
Support, maintenance and other services revenue grew faster, 14% to $1,363.9 million, "in conjunction with the growth of our end customer base, which grew approximately 11% during fiscal 2026." The end-customer count passed 32,000.
Split by recognition type: subscription revenue $2,712.3 million (+12.5%), professional services and other $141.3 million.
Two forward indicators ran well ahead of reported revenue. ARR grew 16% to $2,548.8 million, and remaining performance obligations — contracted revenue not yet recognized — grew 28% to $3,440.4 million, of which the company expects to recognize about 49% within twelve months. Total deferred revenue rose to $2,423.4 million from $2,112.8 million, contributing a $315.0 million working-capital inflow to operating cash flow. When contracted backlog grows more than twice as fast as recognized revenue, the recognized-revenue line is understating what has actually been sold — a normal artifact of a business where a chunk of licence revenue lands upfront and the rest bleeds out over 3.2 years of average contract duration.
Geographically the growth was lopsided toward Europe. EMEA revenue rose 21% to $831.4 million and Other Americas 47% (off a small $73.9 million base), while the U.S. — still 54% of revenue at $1,530.4 million — grew only 9% and Asia Pacific just 6% to $417.8 million. The 10-K does not quantify a currency effect on the EMEA figure, so some unknown part of that 21% is a weaker dollar rather than more software sold.
Margin expanded on spending restraint, not on gross margin
Gross margin was exactly flat at 86.8%. Underneath that flat line, two things cancelled out. Product gross margin improved 0.7 points to 98.6% because cost of product revenue actually fell 24% to $21.4 million "due primarily to a decrease in overhead resulting from lower operating lease and finance lease costs." Services gross margin fell 0.5 points to 73.9%, with personnel costs "growing at a slightly faster rate than support, maintenance and other services revenue." And because the lower-margin services line grew faster than product (14% vs 11%), the revenue mix shifted slightly toward the weaker-margin half. Flat overall was the arithmetic result of those three offsetting moves, not stability.
All of the operating-margin improvement therefore came from operating expenses — the costs of running the business below the gross-profit line. Total operating expenses rose 8% to $2,202.8 million against 12% revenue growth, which is the whole story of the 280-basis-point GAAP operating margin expansion (operating margin is the share of revenue left after all operating costs, before interest and tax):
Sales and marketing: $1,150.3 million, +9% — and critically, down to 40.3% of revenue from 41.6%. Headcount here grew only 3%.
Research and development: $790.9 million, +7%, on 5% headcount growth, with higher IT and facilities costs "partially offset by an increase in reimbursements for technical costs related to certain partner programs."
General and administrative: $261.7 million, +10%, on 9% headcount growth — the fastest-growing headcount pool in the company, which is not where you want it.
Each of those three lines also absorbed severance from the restructuring announced after year-end, discussed next.
A 5% headcount cut booked in FY2026, paid in FY2027
In August 2026 — after the fiscal year closed but before the 10-K was filed — Nutanix announced a plan to reduce global headcount by approximately 5% from a base of roughly 8,350 employees, "following a review of our business structure," intended to "streamline and realign our organizational structure, improve operational efficiency and agility, and reallocate resources toward strategic priorities."
The accounting matters for how you read FY2026's cash figures. Nutanix recognized the full $27.6 million of severance charges in FY2026 results ($17.6 million in sales and marketing, $5.2 million in R&D, $3.7 million in services cost of revenue, $1.1 million in G&A) — but "During the fiscal year ended July 31, 2026, we did not make any cash payments," leaving a $27.6 million accrued liability on the balance sheet. So FY2026's $840.7 million of free cash flow is flattered by an expense that was booked but not paid. The cash goes out in FY2027, alongside an additional $5.4 million to $15.4 million of further charges the company expects to incur.
Cutting 5% of staff is an odd move for a company management describes as facing an expanding market opportunity. The most coherent reading is that it is a margin action rather than a demand signal: sales and marketing headcount had already been held to 3% growth against 12% revenue growth, and this extends the same discipline. But it sits uneasily next to the FY2027 revenue guidance below.
Capital returns, and a strange pair of share prices
Nutanix bought back 9.4 million shares for $482.5 million at a weighted average price of $51.24, including a $300 million accelerated repurchase executed with Bank of America in December 2025. The board raised the authorization twice — by $350 million in August 2025 and $750 million in April 2026 — leaving $728.9 million available at year-end.
Then, in May 2026, Nutanix sold 4,136,789 shares to Advanced Micro Devices in a private placement at $36.26 per share, raising $150.0 million. That is roughly 29% below the average price the company paid for its own stock over the same fiscal year. A strategic placement to a chip partner is not the same transaction as an open-market buyback and the price difference largely reflects where the stock traded in May versus December, but the net effect is that Nutanix spent $482.5 million retiring stock and then issued shares back at a materially lower price. Combined with equity-plan issuance, basic weighted-average shares still rose (267.5 million to 268.7 million); diluted shares fell only slightly, to 292.2 million. The buyback is offsetting dilution, not shrinking the share count.
The balance sheet supports continued repurchases: $777.3 million of cash plus $1,584.2 million of short-term investments against $1,348.7 million of convertible notes (0.25% coupon due 2027, 0.50% due 2029) and an undrawn $500 million revolver. Unrecognized stock compensation of $594.1 million will flow through over about two years, so the dilution pressure does not let up.
Takeaway: Strip out the $1.2 billion non-cash tax release and FY2026 is a good-not-great year: 12% revenue growth — the slowest of the last three — with margin expansion earned entirely through spending restraint rather than pricing or gross margin, which was flat at 86.8%. The genuinely encouraging numbers are the forward ones: ARR +16% and contracted backlog +28%, both well ahead of recognized revenue. The discouraging one is management's own FY2027 revenue guidance, which implies no acceleration at all despite the VMware migration opportunity the 10-K spends a full risk factor describing.
Guidance and outlook
Management's guidance, issued with the August 26, 2026 earnings release:
Guidance
Q1 FY2027
Full-year FY2027
Revenue
$755 – $765M
$3.180 – $3.230B
Non-GAAP operating margin
26% – 28%
24% – 25%
Free cash flow
not guided
$850 – $950M
Diluted shares (non-GAAP)
~294 million
—
Three things stand out.
No acceleration is guided. The FY2027 revenue range implies 11% to 13% growth, midpoint ~12.3% — essentially identical to the 12% just delivered. Nutanix's central strategic argument, laid out at length in the 10-K, is that "our opportunity to increase market share has grown since VMware (now known as VMware by Broadcom), one of our main competitors, was acquired by Broadcom in November 2023," with Broadcom's pricing and licensing changes pushing customers to evaluate alternatives. The same risk factor then explains why that has not translated into faster growth: customers "may remain subject to multi-year contractual commitments, defer migration until their next hardware or software refresh cycle," and "these opportunities may arise in multiple waves over an extended period and may not result in customer commitments or revenue within the periods we anticipate." Management is, in effect, guiding as though the VMware tailwind is a multi-year drip rather than a step change. Given that the ARR and backlog growth rates are running four to sixteen points above revenue growth, there is a reasonable case the guide is conservative — but it is the company's own call.
The margin guide implies deterioration through the year. A 26–28% non-GAAP operating margin in Q1 against 24–25% for the full year means the back three quarters must average well below the first. Some of that is ordinary spending seasonality, but it means the exit-rate margin is not the guided number.
The free cash flow guide is roughly flat to modestly up. $850–950 million against $840.7 million delivered is 1% to 13% growth on 12% revenue growth, and it has to absorb the restructuring cash that FY2026 accrued but never paid, plus $5.4–15.4 million of new charges. At the low end, that is free cash flow essentially standing still.
My read: the operating trajectory is sound but no longer accelerating. Nutanix has reached durable profitability on any measure — three years of cumulative U.S. pre-tax profit, $840.7 million of free cash flow, a positive equity balance for the first time — and the subscription base is compounding faster than reported revenue suggests, which should pull revenue growth up as backlog converts. Against that: growth decelerated six points in a year the competitive environment was supposed to be at its most favorable, all the margin gain came from holding headcount down rather than from the product, and the company just cut 5% of staff. The valuation allowance release is a genuine signal of sustained profitability, but it is a rearview-mirror signal about 2023–2026, not a forecast. The number to watch in FY2027 is whether the 28% backlog growth converts into revenue growth above the guided 12% — if it does not within two or three quarters, the VMware opportunity was smaller or slower than the story required.